title: Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells.
abstract: Artemisinin (ART) is isolated from the medicinal plant Artemisia annua L. To determine its effects on the invasion and metastasis of tumors, the human hepatocellular carcinoma (HCC) cell lines HepG2 and SMMC-7721 were treated with different concentrations of ART. Starting at 12.5μM, ART had inhibitory effects in migration and invasion assays that increased at higher concentrations. The inhibitory effect also became stronger with time, from 24 to 72h. ART significantly inhibited the in vivo metastatic abilities of the HepG2 HCC cell line. ART inhibited the invasion and metastasis of HCC cells both in vitro and in vivo by reducing the level of the MMP2 metalloproteinase, and by inducing the TIMP2 protein. ART activated Cdc42, which enhanced E-cadherin activity, resulting in greater cell-cell adhesion, and significantly reduced metastasis.
authors.affiliation: Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, PR China.
authors.forename: Tan
authors.initials: T
authors.lastname: Weifeng
authors.forename: Shen
authors.initials: S
authors.lastname: Feng
authors.forename: Luo
authors.initials: L
authors.lastname: Xiangji
authors.forename: Su
authors.initials: S
authors.lastname: Changqing
authors.forename: Qiu
authors.initials: Q
authors.lastname: Zhiquan
authors.forename: Zeng
authors.initials: Z
authors.lastname: Huazhong
authors.forename: Yan
authors.initials: Y
authors.lastname: Peining
authors.forename: Yu
authors.initials: Y
authors.lastname: Yong
authors.forename: Wu
authors.initials: W
authors.lastname: Mengchao
authors.forename: Jiang
authors.initials: J
authors.lastname: Xiaoqing
authors.forename: Lau
authors.initials: L
authors.lastname: Wan-Yee
mesh_terms: D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology / Q000627:therapeutic use*; D019306:Artemisia / Q000737:chemistry*; D037621:Artemisinins / Q000494:pharmacology / Q000627:therapeutic use*; D015820:Cadherins / Q000378:metabolism; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000473:pathology; D002448:Cell Adhesion / Q000187:drug effects; D045744:Cell Line, Tumor; D056945:Hep G2 Cells; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D008175:Lung Neoplasms / Q000378:metabolism / Q000517:prevention & control* / Q000556:secondary; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D008517:Phytotherapy; D010936:Plant Extracts / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D037621:Artemisinins; D015820:Cadherins; D010936:Plant Extracts; C031327:artemisinin